Work

Identification of a gene expression signature predictive of clinical benefit in patients with advanced mucosal melanoma (MCM) treated with immune checkpoint blockade.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.9546

Authors: Suthee Rapisuwon, Alexander Noor Shoushtari, Lee S. Gottesdiener, Douglas Buckner Johnson, Daniel Ying Wang, Garrett Thomas Graham, David Goerlitz, Deborah Berry, Michael B. Atkins

Institutions: Georgetown Lombardi Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Vanderbilt University Medical Center, Georgetown University Medical Center, Georgetown University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947555127

Cites:

Cited by:

Related to: 10